Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio Essence (BIOE) Debt to Equity (2020 - 2024)

Bio Essence (BIOE) has 5 years of Debt to Equity data on record, last reported at -$0.9 in Q1 2024.

  • For Q1 2024, Debt to Equity fell 8783.16% year-over-year to -$0.9; the TTM value through Mar 2024 reached -$0.9, down 8783.16%, while the annual FY2023 figure was -$0.02, 32.9% down from the prior year.
  • Debt to Equity reached -$0.9 in Q1 2024 per BIOE's latest filing, down from -$0.02 in the prior quarter.
  • Across five years, Debt to Equity topped out at -$0.01 in Q1 2023 and bottomed at -$0.98 in Q3 2021.
  • Average Debt to Equity over 5 years is -$0.32, with a median of -$0.02 recorded in 2023.
  • Peak YoY movement for Debt to Equity: surged 98.64% in 2022, then plummeted 8783.16% in 2024.
  • A 5-year view of Debt to Equity shows it stood at -$0.74 in 2020, then soared by 97.24% to -$0.02 in 2021, then soared by 43.43% to -$0.01 in 2022, then crashed by 32.9% to -$0.02 in 2023, then plummeted by 5733.22% to -$0.9 in 2024.
  • Per Business Quant database, its latest 3 readings for Debt to Equity were -$0.9 in Q1 2024, -$0.02 in Q4 2023, and -$0.02 in Q3 2023.